Mode
Text Size
Log in / Sign up
N/A N=95 Randomized Double-blind Treatment

Improving Rehabilitation Outcomes After Total Hip Arthroplasty

Total Hip Arthroplasty · Osteoarthritis

Enrolled (actual)
95
Serious AEs
0.0%
Results posted
Apr 2024
Primary outcome: Primary: 6 Minute Walk Test (6MW) — 252.4; 207.0 meters

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Functional Strength Integration (FSI) (Behavioral); Control Group (CON) (Behavioral)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Sep 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
6 Minute Walk Test (6MW)
252.4; 207.0
SECONDARY
4 Meter Walk (4MW)
-0.69; -0.54
SECONDARY
30 Second Sit-to-stand (30 STS)
4.22; 3.39
SECONDARY
Functional Gait Assessment (FGA)
3.71; 3.63
SECONDARY
Isometric Strength
0.15; 0.06; 0.14; 0.02; 0.64; 0.54
SECONDARY
Modified Trendelenburg Test
4.27; 2.81
SECONDARY
Peak Internal Hip Abduction Moment
3.44; 0.62; 3.27; 0.42
SECONDARY
ActiGraph
892; 1014
SECONDARY
Veterans RAND 12-item Health Survey (VR-12)
15.2; 16.4; 4.16; 3.82
SECONDARY
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
-35.0; -38.4
SECONDARY
Patient Activation Measure (PAM)
71.3; 70.6; 3.34; 3.27
SECONDARY
Patient Activation Measure (PAM) Categorical
2; 7; 25; 22; 17; 20
SECONDARY
Motivation Scale
9.42; 9.28

Summary

This study plans to learn more about the effects of physical therapy (PT) following a total hip arthroplasty (THA). The purpose of this study is to compare standard of care PT after THA with a physical therapy program specifically designed to integrate targeted core and hip muscle strength and functional training.

Eligibility Criteria

Inclusion Criteria

  • BMI less than or equal to 40
  • Receiving unilateral primary total hip arthroplasty for osteoarthritis

Exclusion Criteria

  • Severe contralateral leg OA (>= 5/10 pain with stair climbing)
  • Other unstable orthopaedic conditions that limit function
  • Neurological or pulmonary problems that severely limit function
  • Uncontrolled hypertension or diabetes
  • Use of illegal substances
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02920866). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search